- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
Onycholysis is a condition in which the nail plate separates from the nail bed. It is a common dermatological disorder that can be caused by a variety of factors, including trauma, infection, and certain medications. Treatment for onycholysis typically involves topical medications, such as antifungal agents, corticosteroids, and retinoids. These medications are used to reduce inflammation, reduce the risk of infection, and promote nail growth.
The onycholysis drug market is a subset of the larger dermatological drug market. It is composed of a variety of medications used to treat onycholysis, including antifungal agents, corticosteroids, and retinoids. These medications are available in both prescription and over-the-counter forms.
Some companies in the onycholysis drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of medications used to treat onycholysis, including antifungal agents, corticosteroids, and retinoids. Show Less Read more